Patent Number: 8,722,691

Title: Azolopyrimidines as inhibitors of cannabinoid 1 activity

Abstract: The invention provides compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). The compounds are of the Formulae Ia, Ic, Ig and Ik: ##STR00001## ##STR00002##

Inventors: He; Xiaohui (San Diego, CA), Yang; Kunyong (San Diego, CA), Liu; Hong (San Diego, CA), Ellis; David Archer (San Diego, CA)

Assignee: IRM LLC

International Classification: C07D 487/04 (20060101); A61K 31/519 (20060101); A61P 3/04 (20060101)

Expiration Date: 5/13/12018